Pulmonary Rehabilitation Program and PROactive Tool
PROactive
Impact of a Pulmonary Rehabilitation Program on the PROactive Tool
1 other identifier
interventional
115
1 country
1
Brief Summary
Pulmonary rehabilitation is an essential non pharmacological treatment option which reduces dyspnea sensations, increase exercise tolerance, improves health related quality of life and reduces the burden on health care resources (1). Pulmonary rehabilitation is likely an ideal intervention to validate the PROactive tool as responses to pulmonary rehabilitation are clinically significant in terms of exercise tolerance and particularly activity related symptoms. Nevertheless, the response to pulmonary rehabilitation is variable and about one out of three patients does not present a clinically important response. Pulmonary rehabilitation may therefore be an intervention that allows studying the conceptual model around the PROactive tools, anchoring the new PROs (Patient Report Outcome) to outcomes that are well known to change with rehabilitation: exercise induced symptoms, functional exercise tolerance and health related quality of life. Study objectives Main objectives A primary aim is to test reliability of the paper-pencil versus the electronic scoring version of the PROactive tool in terms of assessing the effect of pulmonary rehabilitation on the components of the PROactive tool and on the mode of administration. The secondary aim of the proposed project is to investigate the effects of a multidisciplinary outpatient hospital-based, pulmonary rehabilitation program on: i) daily physical activity (number of daily steps, vector magnitude unit and movement intensity and ii) the components of the Proactive tool. Additional study objectives A third aim of this project is to investigate whether the magnitude of change in daily physical activity and the components of the PROactive tool in general is associated with the magnitude of changes in frequently used rehabilitation related end-points including, functional capacity, exercise capacity and health-related quality of life following the completion of a comprehensive pulmonary rehabilitation program. A forth aim of this project is to investigate whether the magnitude of change in daily physical activity and the components of the PROactive tool in general is associated with the magnitude of changes in physiological indices including cardiovascular and respiratory adaptations following completion of a comprehensive pulmonary rehabilitation program.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease
Started Oct 2013
Typical duration for not_applicable chronic-obstructive-pulmonary-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2013
CompletedFirst Submitted
Initial submission to the registry
April 21, 2015
CompletedFirst Posted
Study publicly available on registry
May 8, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2016
CompletedMay 6, 2016
May 1, 2016
2.8 years
April 21, 2015
May 5, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Proactive tool (clinical visit version)
Proactive tool is a patient-reported outcome which combines a 12-item self-administrated questionnaire and activity monitor score in order to assess daily physical activity in patients with COPD. Proactive tool can be scored as a simple sum of the scores of the items (each item can be scored mostly from 0 to 4), with lower scores indicating poorer physical activity.
7 days
Secondary Outcomes (1)
Daily Physical activity as measured by a validated for COPD patients triaxial accelerometers
7 days
Study Arms (2)
Pulmonary Rehabilitation
EXPERIMENTALThe rehabilitation program will be multidisciplinary and will include supervised exercise training (interval exercise and resistance exercises), breathing control and relaxation techniques, methods of clearance of pulmonary secretions, disease education, dietary advice, and psychological support on issues relating to chronic disability.
Control
NO INTERVENTIONIn addition, a control group (Group C) which will not participate in the rehabilitation program (usual care) will be include at the same time as patients in Group A and B so as to be able and independently address study objectives 2 and 3 and 4. Group C will also randomized to those into paper-pencil version and electronic version.
Interventions
The rehabilitation program will be multidisciplinary and will include mandatory supervised exercise training at appropriate training intensity, other components of the program can be breathing control and relaxation techniques, methods of clearance of pulmonary secretions, disease education, dietary advice, and psychological support on issues relating to chronic disability. Six minute walking tests, and improvements in dyspnea sensation (CRDQ) will be used to benchmark the effect of a program provided by a given team.
Eligibility Criteria
You may qualify if:
- Clinically stable patients with COPD will be recruited from the academic centers' Outpatient Clinic on the following entry criteria:
- a post-bronchodilator forced expiratory volume in one second (FEV1) \<70% predicted without significant reversibility (\<12% change of the initial FEV1 value or \<200 ml) and
- optimal medical therapy according to Global Initiative for Chronic Obstructive Lung Disease (GOLD) (6).
You may not qualify if:
- Orthopedic, neurological, and other musculoskeletal complaints that could impair normal movement patterns,
- respiratory diseases other than COPD (e.g. asthma),
- hospital admission or COPD exacerbations within the previous 4 weeks
- patients not on optimal pharmacotherapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pulmonary Rehabilitation Centre, Sotiria Hospital, 1st Departments of Respiratory Medicine, National and Kapodistrian University of Athens
Athens, Greece
Related Publications (2)
1. Nici L. American Thoracic Society/ Respiratory Society statement of pulmonary rehabilitation. American Journal Respiratory Critical Care Medicine 173: 1390-1413, 2006. 2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Executive summary. 2005 3. Rabe K.F. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. American Journal Respiratory Critical Care Medicine 176: 532-555, 2007. 4. Charloux A. Exercise by a new impedance cardiography device: comparison with the direct Fick method. European of Applied Physiology 82: 313-320, 2000.
BACKGROUNDLouvaris Z, Spetsioti S, Kortianou EA, Vasilopoulou M, Nasis I, Kaltsakas G, Koulouris NG, Vogiatzis I. Interval training induces clinically meaningful effects in daily activity levels in COPD. Eur Respir J. 2016 Aug;48(2):567-70. doi: 10.1183/13993003.00679-2016. Epub 2016 Jun 23. No abstract available.
PMID: 27338191DERIVED
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
CHARALAMBOS ROUSSOS, PhD, MD
Thorax Research Foundation
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Invetsigator
Study Record Dates
First Submitted
April 21, 2015
First Posted
May 8, 2015
Study Start
October 1, 2013
Primary Completion
July 1, 2016
Study Completion
July 1, 2016
Last Updated
May 6, 2016
Record last verified: 2016-05